WuXi Biologics WuXi AppTec is expected to provide world-class integrated biopharmace
WuXi Biologics is a subsidiary of the WuXi AppTec Group with branches in Wuxi, Shanghai and Suzhou. As a platform for innovative companies to realize their dream of developing new drugs, WuXi AppTec is expected to provide world-class integrated biopharmaceutical R&D and manufacturing services to more innovative biotech companies at home and abroad in the future, accelerating the process of bringing innovative biopharmaceuticals to market in China for the benefit of patients.
Sanlian board Shenma power: the company's gross profit margin declined to a certain extent in the first quarter
Tesla unveiled a new giant 360mwh Megapack energy storage project
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
The Russian court of appeal approved a fine of $26.4 million for meta
2022 China AI Health 30 Report
Blue lithium core: the application for non-public offering of shares was approved
Boten increased cdmo capacity construction of API
Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted
Vosges shares: the price of products in overseas markets will increase by 3-5% in 2021, and there is still a price increase plan this year
Yaoming biological suspended trading in Hong Kong
Esten: the rumor that "Xinsong robot will be acquired" is not true without direct cooperation with the Winter Olympic Games
Agricultural driverless enterprise "Zhongke motive power" won tens of millions of yuan of a + round financing
HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D
Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.
Apr 23, 2023 12:20 PM
The battery plant jointly built by SK innovation and Ford was started in December last year
Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.
Wuxi apptec diving limit in the afternoon
Radio and television express: a variety of products and applications have been certified by financial Xinchuang ecological laboratory